Viewing data from:

SUMATRIPTAN

ANDA

SUMATRIPTAN | A213465 | PADAGIS ISRAEL PHARMACEUTICALS LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: IMITREX(TE code: AB)

API Supply Chain3 active DMFs4 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SMS PHARMACEUTICALS LTDSUMATRIPTAN USP (ALTERNATIVE SYNTHESIS)

DMF 209062007

MSN PHARMACHEM PRIVATE LTDSUMATRIPTAN USP [ROUTE CODE - "SN"]

DMF 234422010

MOEHS IBERICA SLSUMATRIPTAN

DMF 240262010

QUIMICA SINTETICA SAInactiveSUMATRIPTAN

DMF 169032003

SMS PHARMACEUTICALS LTDInactiveSUMATRIPTAN USP

DMF 182872005

NATCO PHARMA LTDInactiveSUMATRIPTAN

DMF 192122006

HOVIONE FARMACIENCIA SAInactiveSUMATRIPTAN USP

DMF 246422011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 20MG/SPRAY

0 patents0 exclusivities▴

SPRAY;NASAL | Approved: Sep 21, 2020

No patent or exclusivity listings for this strength.

#002 — 5MG/SPRAY

0 patents0 exclusivities▾

SPRAY;NASAL | Approved: Sep 21, 2020